A Double-Blind, Randomized, Placebo Controlled, Cross-Over, Safety Tolerance and Experimental Hyperalgesia Study of Oral NGX426 in Healthy Male Volunteers

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 26 Mar 2013

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

16 Nov 2009 Results will be presented at the 12th International Conference on the Mechanisms and Treatment of Neuropathic Pain, to be held 20-21 Nov 2009, according to a Raptor Pharmaceutical Corp media release.
06 Jun 2008 New trial record.
05 Jun 2008 Status changed from not yet recruiting to recruiting, reported in a TorreyPines media release.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com